Takeda Pharmaceuticals America, Inc.
UnclaimedPharmaceutical Preparation ManufacturingCambridge, MA
Founded
1993
Primary NAICS
325412
CAGE code
3FLV7
Federal awards
$3.1M
Overview
Transforming cancer care through innovative medicines, pioneering research & patient-first approach. Explore our pipeline, therapies & commitment.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $246,517 | 26 |
| 2026 | Department of Justice | $100,435 | 7 |
| 2025 | Department of Veterans Affairs | $491,859 | 33 |
| 2025 | Department of Justice | $14,297 | 1 |
| 2024 | Department of Veterans Affairs | $712,596 | 51 |
| 2023 | Department of Veterans Affairs | $464,980 | 35 |
| 2022 | Department of Veterans Affairs | $1,048,832 | 28 |